Prevalence, clinical characteristics, and evolution of COVID-19 infection among patients and healthcare staff of a national reference hemodialysis center in Peru
Keywords:
SARS-CoV-2, COVID-19, coronavirus, hemodialysis units in hospital, renal dialysis, hemodialysis, chronic renal failure, hospitalization
Abstract
Objective: To determine the prevalence, clinical characteristics, and evolution of the patients and healthcare staff with COVID-19 infection in a national reference hemodialysis center. Methodology. Observational and retrospective study in a cohort of patients on chronic hemodialysis and healthcare staff with COVID-19 infection at the Dos de Mayo National Hospital in Lima from March 1 to June 12, 2020. Results. Were evaluated 48 patients and 52 healthcare staff. Were positive for COVID-19 33.3% of patients and 7.6% of healthcare staff. Were symptomatic 56.2% of the patients and 18.7% required hospitalization. No one on the staff had symptoms. To date, none of the patients evaluated has required mechanical ventilation or has died. Conclusions. COVID-19 infection among patients is high. Two out of ten patients have required hospitalization, without any deceased.
References
1) Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5.
2) Acosta G, Escobar G, Bernaola G, Alfaro J, Taype W, Marcos C, et al. Caracterización de pacientes con COVID-19 grave atendidos en un hospital de referencia nacional del Perú. Rev Peru Med Exp Salud Pública. 2020;37(2):253-8. doi: 10.17843/rpmesp.2020.372.5437.
3) World Health Organization. Novel Coronavirus (2019-nCoV), Situation Report 1, 21 january 2020 [Internet]. WHO: 2020, [5 p.]. Disponible en: (consulta: 20/05/2020).
4) Wang X, Fang X, Cai Z, Wu X, Gao X, Min J, et al. Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: a systemic review and meta-analysis. Research (Wash DC). 2020;2020:2402961. doi: 10.34133/2020/2402961.
5) Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int UrolNephrol. 2020;52(6):1193-4. doi: 10.1007/s11255-020-02451-9.
6) Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829-838. doi: 10.1016/j.kint.2020.03.005.
7) Ikizler TA, Kliger AS. Minimizing the risk of COVID-19 among patients on dialysis. Nat Rev Nephrol. 2020;16(6):311-3. doi: 10.1038/s41581-020-0280-y.
8) Ma Y, Diao B, Lv X, Zhu J, Liang W, Liu L, et al. 2019 novel coronavirus disease in hemodialysis (HD) patients: report from one HD center in Wuhan, China. medRxiv preprint [published: feb. 27, 2020]. doi: 10.1101/2020.02.24.20027201.
9) Manganaro M, Baldovino S; Working Group of the Piedmont and Aosta Valley Section of the SIN. First considerations on the SARS-CoV-2 epidemic in the Dialysis Units of Piedmont and Aosta Valley, Northern Italy. J Nephrol. 2020;33(3):393-5. doi: 10.1007/s40620-020-00732-1.
10) Perú. Ministerio de Salud. Sala Situacional COVID-19 [Internet]. Disponible en: (consulta: 13/06/2020).
11) ¿Por qué Perú es el segundo país de América Latina con más casos de COVID-19? [Internet]. Semana, 23 mayo 2020. Disponible en:
12) Herrera-Añazco P, Atamari-Anahui N, Flores-Benítes V. Número de nefrólogos, servicios de hemodiálisis y tendencia de la prevalencia de enfermedad renal crónica en el Ministerio de Salud de Perú. Rev Peru Med Exp Salud Pública. 2019;36(1):62-7. doi: 10.17843/rpmesp.2019.361.4253.
13) Herrera-Añazco P, Benítes-Zapata VA, Hernández AV. Factores asociados a mortalidad intrahospitalaria de una población en hemodiálisis en el Perú. Rev Peru Med Exp Salud Pública. 2015;32(3):479‐84. doi: 10.17843/rpmesp.2015.323.1677.
14) Soto A. Barreras para una atención eficaz en los hospitales de referencia del Ministerio de Salud del Perú: atendiendo pacientes en el siglo XXI con recursos del siglo XX. Rev Peru Med Exp Salud Pública. 2019;36(2):304-11. doi: 10.17843/rpmesp.2019.362.4425.
15) Basile C, Combe C, Pizzarelli F, Covic A, Davenport A, Kanbay M, et al. Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres. Nephrol Dial Transplant. 2020;35(5):737-41. doi: 10.1093/ndt/gfaa069.
16) Meijers B, Messa P, Ronco C. Safeguarding the maintenance hemodialysis patient population during the coronavirus disease 19 pandemic. Blood Purif. 2020;49(3):259-64. doi: 10.1159/000507537.
17) Park HC, Kim DH, Yoo KD, Kim YG, Lee SH, Yoon HE, et al.; Korean Society of Nephrology COVID-19 Task Force Team. Korean clinical practice guidelines for preventing transmission of coronavirus disease 2019 (COVID-19) in hemodialysis facilities. Kidney Res Clin Pract. 2020;39(2):145-50. doi: 10.23876/j.krcp.20.046.
18) Li J, Li SX, Zhao LF, Kong DL, Guo ZY. Management recommendations for patients with chronic kidney disease during the novel coronavirus disease 2019 (COVID-19) epidemic. Chronic Dis Transl Med. 2020;6(2):119-23. doi: 10.1016/j.cdtm.2020.05.001.
19) Taj M, Kurmanaev A. El virus exhibe las debilidades de la historia de éxito de Perú. The New York Times, 16 jun. 2020. Disponible en: (consulta: 13/06/2020).
20) Sakurai A, Sasaki T, Kato S, Hayashi M, Tsuzuki SI, Ishihara T, et al. Natural history of asymptomatic SARS-CoV-2 infection. N Engl J Med. 2020;383(9):885-6. doi: 10.1056/NEJMc2013020.
21) Wu J, Li J, Zhu G, Zhang Y, Bi Z, Yu Y, et al. Clinical features of maintenance hemodialysis patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Clin J Am Soc Nephrol. 2020;15(8):1139-45. doi: 10.2215/CJN.04160320.
22) Valeri AM, Robbins-Juarez SY, Stevens JS, Ahn W, Rao MK, Radhakrishnan J, et al. Presentation and outcomes of patients with ESKD and COVID-19. J Am Soc Nephrol. 2020;31(7):1409-15. doi: 10.1681/ASN.2020040470.
23) Jung HY, Lim JH, Kang SH, Kim SG, Lee YH, Lee J, et al. Outcomes of COVID-19 among patients on in-center hemodialysis: an experience from the epicenter in South Korea. J Clin Med. 2020;9(6):1688. doi: 10.3390/jcm9061688.
2) Acosta G, Escobar G, Bernaola G, Alfaro J, Taype W, Marcos C, et al. Caracterización de pacientes con COVID-19 grave atendidos en un hospital de referencia nacional del Perú. Rev Peru Med Exp Salud Pública. 2020;37(2):253-8. doi: 10.17843/rpmesp.2020.372.5437.
3) World Health Organization. Novel Coronavirus (2019-nCoV), Situation Report 1, 21 january 2020 [Internet]. WHO: 2020, [5 p.]. Disponible en:
4) Wang X, Fang X, Cai Z, Wu X, Gao X, Min J, et al. Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: a systemic review and meta-analysis. Research (Wash DC). 2020;2020:2402961. doi: 10.34133/2020/2402961.
5) Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int UrolNephrol. 2020;52(6):1193-4. doi: 10.1007/s11255-020-02451-9.
6) Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829-838. doi: 10.1016/j.kint.2020.03.005.
7) Ikizler TA, Kliger AS. Minimizing the risk of COVID-19 among patients on dialysis. Nat Rev Nephrol. 2020;16(6):311-3. doi: 10.1038/s41581-020-0280-y.
8) Ma Y, Diao B, Lv X, Zhu J, Liang W, Liu L, et al. 2019 novel coronavirus disease in hemodialysis (HD) patients: report from one HD center in Wuhan, China. medRxiv preprint [published: feb. 27, 2020]. doi: 10.1101/2020.02.24.20027201.
9) Manganaro M, Baldovino S; Working Group of the Piedmont and Aosta Valley Section of the SIN. First considerations on the SARS-CoV-2 epidemic in the Dialysis Units of Piedmont and Aosta Valley, Northern Italy. J Nephrol. 2020;33(3):393-5. doi: 10.1007/s40620-020-00732-1.
10) Perú. Ministerio de Salud. Sala Situacional COVID-19 [Internet]. Disponible en:
11) ¿Por qué Perú es el segundo país de América Latina con más casos de COVID-19? [Internet]. Semana, 23 mayo 2020. Disponible en:
12) Herrera-Añazco P, Atamari-Anahui N, Flores-Benítes V. Número de nefrólogos, servicios de hemodiálisis y tendencia de la prevalencia de enfermedad renal crónica en el Ministerio de Salud de Perú. Rev Peru Med Exp Salud Pública. 2019;36(1):62-7. doi: 10.17843/rpmesp.2019.361.4253.
13) Herrera-Añazco P, Benítes-Zapata VA, Hernández AV. Factores asociados a mortalidad intrahospitalaria de una población en hemodiálisis en el Perú. Rev Peru Med Exp Salud Pública. 2015;32(3):479‐84. doi: 10.17843/rpmesp.2015.323.1677.
14) Soto A. Barreras para una atención eficaz en los hospitales de referencia del Ministerio de Salud del Perú: atendiendo pacientes en el siglo XXI con recursos del siglo XX. Rev Peru Med Exp Salud Pública. 2019;36(2):304-11. doi: 10.17843/rpmesp.2019.362.4425.
15) Basile C, Combe C, Pizzarelli F, Covic A, Davenport A, Kanbay M, et al. Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres. Nephrol Dial Transplant. 2020;35(5):737-41. doi: 10.1093/ndt/gfaa069.
16) Meijers B, Messa P, Ronco C. Safeguarding the maintenance hemodialysis patient population during the coronavirus disease 19 pandemic. Blood Purif. 2020;49(3):259-64. doi: 10.1159/000507537.
17) Park HC, Kim DH, Yoo KD, Kim YG, Lee SH, Yoon HE, et al.; Korean Society of Nephrology COVID-19 Task Force Team. Korean clinical practice guidelines for preventing transmission of coronavirus disease 2019 (COVID-19) in hemodialysis facilities. Kidney Res Clin Pract. 2020;39(2):145-50. doi: 10.23876/j.krcp.20.046.
18) Li J, Li SX, Zhao LF, Kong DL, Guo ZY. Management recommendations for patients with chronic kidney disease during the novel coronavirus disease 2019 (COVID-19) epidemic. Chronic Dis Transl Med. 2020;6(2):119-23. doi: 10.1016/j.cdtm.2020.05.001.
19) Taj M, Kurmanaev A. El virus exhibe las debilidades de la historia de éxito de Perú. The New York Times, 16 jun. 2020. Disponible en:
20) Sakurai A, Sasaki T, Kato S, Hayashi M, Tsuzuki SI, Ishihara T, et al. Natural history of asymptomatic SARS-CoV-2 infection. N Engl J Med. 2020;383(9):885-6. doi: 10.1056/NEJMc2013020.
21) Wu J, Li J, Zhu G, Zhang Y, Bi Z, Yu Y, et al. Clinical features of maintenance hemodialysis patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Clin J Am Soc Nephrol. 2020;15(8):1139-45. doi: 10.2215/CJN.04160320.
22) Valeri AM, Robbins-Juarez SY, Stevens JS, Ahn W, Rao MK, Radhakrishnan J, et al. Presentation and outcomes of patients with ESKD and COVID-19. J Am Soc Nephrol. 2020;31(7):1409-15. doi: 10.1681/ASN.2020040470.
23) Jung HY, Lim JH, Kang SH, Kim SG, Lee YH, Lee J, et al. Outcomes of COVID-19 among patients on in-center hemodialysis: an experience from the epicenter in South Korea. J Clin Med. 2020;9(6):1688. doi: 10.3390/jcm9061688.
Published
2021-03-25
How to Cite
1.
Herrera-Añazco P, Sánchez-Pérez L, Córdova-Cueva L. Prevalence, clinical characteristics, and evolution of COVID-19 infection among patients and healthcare staff of a national reference hemodialysis center in Peru. Rev Nefrol Dial Traspl. [Internet]. 2021Mar.25 [cited 2024Jul.16];41(1):42-7. Available from: http://revistarenal.org.ar/index.php/rndt/article/view/616
Section
Case Report
Copyright (c) 2021 Revista de Nefrología, Diálisis y Trasplante
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
